I totally agree with you Farviewhill. There is no partnership concluded since it is a material event which shall be released by ACTC. Shareholders do not want to dilute the company. I can understand. But if they do not dilute they will not be able to find the funds for Phase II and III. ACTC has at leat 5-6 years to go prior to commercialization of the RPE cells. They need money.
So what do you prefer: loosing your total investment because ACTC is not able to handle the Phase II and III; or Dilute to get a lot of gains after they succeed with the commercialization?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.